advanced pancreatic cancer
Showing 1 - 25 of 41
Advanced Pancreatic Cancer Trial in Shanghai (Pimicotinib (ABSK021))
Recruiting
- Advanced Pancreatic Cancer
- Pimicotinib (ABSK021)
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Oct 26, 2023
Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Modena (Olaparib 150 MG)
Recruiting
- Advanced Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Olaparib 150 MG
-
Modena, ItalyAou Modena
Oct 5, 2023
Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)
Recruiting
- Advanced Pancreatic Cancer
- Personalized neoantigen tumor vaccine
-
Qionghai, Hainan, ChinaRuijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023
Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )
Advanced Pancreatic Cancer Trial in Shanghai (JS107, JS107 combination with Toripalimab)
Not yet recruiting
- Advanced Pancreatic Cancer
- JS107
- JS107 combination with Toripalimab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Dec 19, 2022
Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)
Recruiting
- Advanced Pancreatic Cancer
- CT-707
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 17, 2022
Advanced Pancreatic Cancer, Solid Tumor Malignancies Trial run by the (ProAgio)
Recruiting
- Advanced Pancreatic Cancer
- Solid Tumor Malignancies
-
Bethesda, MarylandNational Cancer Institute
Sep 26, 2022
Advanced Pancreatic Cancer Trial in Shanghai (Chemotherapy guided by organoid drug sensitivity test)
Recruiting
- Advanced Pancreatic Cancer
- Chemotherapy guided by organoid drug sensitivity test
-
Shanghai, ChinaChanghai Hospital
Jul 29, 2022
Metastatic Pancreatic Cancer, Advanced Pancreatic Cancer Trial in Lyon (Tumor samples (archival FFPE) and blood samples)
Recruiting
- Metastatic Pancreatic Cancer
- Advanced Pancreatic Cancer
- Tumor samples (archival FFPE) and blood samples
-
Lyon, FranceCentre Léon Bérard
Jul 21, 2022
Advanced Pancreatic Cancer Trial in Nanjing (Adoptive TIL-TCM transfer therapy)
Recruiting
- Advanced Pancreatic Cancer
- Adoptive TIL-TCM transfer therapy
-
Nanjing, Jiangsu, ChinaJinling Hospital
Jun 29, 2022
Advanced Pancreatic Cancer Trial in Worldwide (Cabiralizumab, Nab-paclitaxel, Onivyde)
Active, not recruiting
- Advanced Pancreatic Cancer
- Cabiralizumab
- +8 more
-
Phoenix, Arizona
- +40 more
Apr 6, 2022
Advanced Pancreatic Cancer Trial in Xuzhou (Envafolimab, Endostar, Nab paclitaxel)
Not yet recruiting
- Advanced Pancreatic Cancer
- Envafolimab
- +3 more
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Mar 18, 2022
Advanced Pancreatic Cancer Trial in Baltimore (galeterone, Gemcitabine)
Recruiting
- Advanced Pancreatic Cancer
-
Baltimore, MarylandUniversity of Maryland Medical Center
Mar 10, 2022
Advanced Pancreatic Cancer Trial in Hangzhou (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in
Recruiting
- Advanced Pancreatic Cancer
- Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in combination with Nivolumab
-
Hangzhou, Zhejiang, Chinathe First Affiliated Hospital, School of Medicine, Zhejiang Univ
Mar 8, 2022
Advanced Pancreatic Cancer Trial in Shanghai (APG-1387 for Injection, Gemcitabine, Nab paclitaxel)
Recruiting
- Advanced Pancreatic Cancer
- APG-1387 for Injection
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 26, 2022
Advanced Pancreatic Cancer Trial in Beijing (Irinotecan liposome;oxaliplatin;5-FU(Fluorouracil Injection);LV(Calcium Folinate
Enrolling by invitation
- Advanced Pancreatic Cancer
- Irinotecan liposome;oxaliplatin;5-FU(Fluorouracil Injection);LV(Calcium Folinate Injection)
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jan 17, 2022
Advanced Hepatocellular Carcinoma, Advanced Colorectal Cancer, Advanced Gastric Cancer Trial in Hangzhou (EPCAM CAR-T)
Recruiting
- Advanced Hepatocellular Carcinoma
- +3 more
- EPCAM CAR-T
-
Hangzhou, ChinaFirst affiliated hospital, School of Medicine, Zhejiang Universi
Jan 12, 2022
Advanced Pancreatic Cancer Trial in Ireland (Paricalcitol, Gemcitabine (GEM) and Nab-paclitaxel)
Active, not recruiting
- Advanced Pancreatic Cancer
- Paricalcitol
- Gemcitabine (GEM) and Nab-paclitaxel
-
Dublin, Dublin 24, Ireland
- +5 more
Nov 11, 2021
Advanced Pancreatic Cancer, Advanced Solid Tumor Trial in Toledo (Metformin, Simvastatin, Digoxin)
Recruiting
- Advanced Pancreatic Cancer
- Advanced Solid Tumor
- Metformin
- +2 more
-
Toledo, OhioUniversity of Toledo, Eleanor N. Dana Cancer Center
Nov 16, 2021
Advanced Pancreatic Cancer Trial in Worldwide (IMM-101, Gemcitabine)
Completed
- Advanced Pancreatic Cancer
- IMM-101
- Gemcitabine
-
Nicosia, Strovolos, Cyprus
- +20 more
Nov 3, 2021
Advanced Pancreatic Cancer Trial (Mitoxantrone Hydrochloride Liposome injection)
Not yet recruiting
- Advanced Pancreatic Cancer
- Mitoxantrone Hydrochloride Liposome injection
- (no location specified)
Oct 19, 2021
Information Tool for People With Advanced Pancreatic Cancer
Completed
- Advanced Pancreatic Cancer
- web-based interactive tool
-
Bournemouth, United Kingdom
- +3 more
Oct 7, 2021
Pancreatic Cancer, Advanced Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in New York, Charlottesville
Active, not recruiting
- Pancreatic Cancer
- +3 more
- anti-EGFR-bispecific antibody armed activated T-cells
-
New York, New York
- +1 more
Oct 7, 2021
Advanced Pancreatic Cancer Trial in Shanghai (SHR-A1904)
Recruiting
- Advanced Pancreatic Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 18, 2021
Anlotinib, Anti-PD-1 Antibody, Advanced Pancreatic Cancer Trial in Beijing (Anlotinib plus AK105)
Not yet recruiting
- Anlotinib
- +2 more
- Anlotinib plus AK105
-
Beijing, Beijing, ChinaDepartment of Medical Oncology, Peking Union Medical College Hos
Mar 16, 2021